Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice

Journal of Clinical Investigation

Volumn 102, Issue 10, 1998, Pages 1807-1814

  Yasuda, Hisafumi ^a   Nagata, Masao ^a   Arisawa, Kenji ^a   Yoshida, Reiko ^a   Fujihira, Kazuhiro ^a   Okamoto, Naoko ^a   Moriyama, Hiroaki ^a   Miki, Masatoshi ^a   Saito, Izumi ^b   Hamada, Hirofumi ^c   Yokono, Koichi ^a   Kasuga, Masato ^a  

^a KOBE UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CANCER INSTITUTE   (Japan)

Author keywords

Adenoviral vector; Gene therapy; Transforming growth factor ; Transplantation; Type 1 diabetes

Indexed keywords

INSULIN; INTERLEUKIN 12; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DNA TRANSFECTION; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GRAFT SURVIVAL; INSULIN RELEASE; ISOGRAFT; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

EID: 7844230594     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2675     Document Type: Article

References (49)

1. Eisenbarth, G.S. 1986. Type I diabetes mellitus: a chronic autoimmune disease. N. Engl. J. Med. 314:1360-1368.
2. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. (Tokyo). 29:1-13.
3. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell. 85:291-297.
4. Rabinovitch, A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation. Diabetes. 43:613-621.
5. Mosmann, T.R., and R.L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
6. Fitch, F.W., M.D. McKisic, D.W. Lancki, and T.F. Gajewski. 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11: 29-48.
7. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper lymphocytes. Nature. 383:787-793.
8. + islet-specific T cell clone. Science. 249:1433-1436.
9. + T cells in nonobese diabetic mice. J. Immunol. 151: 1723-1730.
10. Katz, J.D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science. 268:1185-1188.
11. Rapoport, M.J., A. Jaramillo, D. Zipris, A.H. Lazarus, D.V. Serreze, E.H. Leiter, P. Cyopick, J.S. Danska, and T.L. Delovitch. 1993. Interleukin-4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:87-99.
12. Pennline, K.J., E. Roque-Gaffney, and M. Monahan. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:165-175.
13. Rabinovich, A., W.L. Suarez-Pinzon, O. Sorensen, R.C. Bleackey, and R.F. Power. 1995. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154:4874-4882.
14. + T cells to enhance priming for interferon-γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10192.
15. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
16. Mattner, F., S. Fischer, S. Guckes, S. Jin, H. Kaulen, E. Schmitt, E. Rude, and T. Germann. 1993. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23:2202-2208.
17. Gillssen, S., D. Carvajal, P. Ling, F.J. Podlaski, D.L. Stremlo, P.C. Familletti, U. Gubler, D.H. Presky, A.S. Stern, and M.K. Gately. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:200-206.
18. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M.K. Gately, and L. Adorini. 1995. Interleukin-12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817-821.
19. 2. Diabetologia. 40:641-646.
20. Trembleau, S., G. Penna, S. Gregori, M.K. Gately, and L. Adorini. 1997. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur. J. Immunol. 27:2330-2339.
21. Sutherland, D.E., F.C. Goetz, and R.K. Siebley. 1989. Recurrence of disease in pancreas transplants. Diabetes. 38(Suppl. 1):85-87.
22. Mallegren, A., A.H. Schnell, B. Petersson, and A. Andersson. 1986. The renal subcapsular site offers better growth conditions for transplanted mouse pancreatic islet cells than liver or spleen. Diabetologia. 29:670-672.
23. Wang, T., B. Singh, G.L. Warnock, and R.V. Rajotte. 1992. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes. 41:114-117.
24. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA. 88:527-531.
25. Rabinovitch, A., O. Sorensen, W.L. Suarez-Pinzon, R.F. Power, R.V. Rajotte, and R.C. Bleackley. 1994. Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon gamma mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia. 37:833-837.
26. Efrat, S., G. Fejer, M. Brownlee, and M.S. Horwitz. 1995. Prolonged survival of pancreatic islet allografts mediated by adenoviral immunoregulatory transgenes. Proc. Natl. Acad. Sci. USA. 92:6947-6951.
27. von Herrath, M.G., S. Efrat, M.B.A. Oldstone, and M.S. Horwitz. 1997. Expression of adenoviral E3 transgenes in β cells prevents autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 94:9808-9813.
28. Graham, F.L., and L. Prevec. 1991. Manipulation of adenovirus vectors. In Methods in Molecular Biology. E.J. Murray, editor. The Human Press, Clifton. NJ. 109-128.
29. Saito, I., Y. Oya, K. Yamamoto, T. Yuasa, and H. Shimojo. 1985. Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J. Virol. 54:711-719.
30. Nakamura, Y., H. Wakimoto, J. Abe, Y. Kanegae, I. Saito, M. Aoyagi, K. Hirakawa, and H. Hamada. 1994. Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2. Cancer. Res. 54:5757-5760.
31. Nagata, M., K. Yokono, M. Hayakawa, Y. Kawase, N. Hatamori, W. Ogawa, K. Yonezawa, K. Shii, and S. Baba. 1989. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice. J. Immunol. 143: 1155-1162.
32. Zhang, Z.J., L. Davidson, G. Eisenbarth, and H.L. Weiner. 1991. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA. 88:10252-10256.
33. Harrison, L.C., C.M. Dempsey, D.R. Kramer, and K. Takahashi. 1996. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184:2167-2174.
34. Moritani, M., K. Yoshimoto, S. Ii, M. Konda, H. Iwahana, T. Yamaoka, T. Sano, N. Nakano, H. Kikutani, and M. Itakura. 1996. Prevention of adaptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes. J. Clin. Invest. 98:1851-1859.
35. Hall, B.M. 1991. Cells mediating allograft rejection. Transplantation. 51: 1141-1151.
36. Hancock, W.W., M. Polanski, J. Zhang, N. Blogg, and H.L. Weiner. 1995. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and 10, transforming growth factor-β, and prostaglandin-E. Am. J. Pathol. 147:1193-1199.
37. Muir, A., A. Peck, M. Clare-Salzler, Y.H. Song, J. Cornelius, R. Luchetta, J. Krischer, and N. Maclaren. 1995. Insulin immunization of non-obese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon gamma transcription. J. Clin. Invest. 95:628-634.
38. Rabinovitch, A., W.L. Suarez-Pinzon, and O. Sorensen. 1996. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice. J. Autoimmun. 9:645-651.
39. Rothe, H., V. Burkart, A. Faust, and H. Kolb. 1996. Interleukin-12 gene expression is associated with development of diabetes mellitus in non-obese diabetic mice. Diabetologia. 39:119-122.
40. Moore, K.W., A. O'Garra, R.W. Malefyt, P. Vieira, and T.R. Mosmann. 1993, Interleukin-10. Annu. Rev. Immunol. 11:165-190.
41. Zheng, X.X., A.W. Steele, W.W. Hancock, A.C. Stevens, P.W. Nickerson, P. Roy-Chaudhury, Y. Tian, and T.B. Strom. 1997. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J. Immunol. 158:4507-4513.
42. Wogensen, L., M.S. Lee, and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp. Med. 179:1379-1384.
43. Moritani, M., K. Yoshimoto, F. Tashiro, C. Hashimoto, J. Miyazaki, S. Ii, E. Kudo, H. Iwahana, Y. Hayashi, T. Sano, and M. Itakura. 1994. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6:1927-1936.
44. Yang, Y., Q. Li, H.C.J. Ertl, and J.M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
45. Smith, D.K., G.S. Korbutt, W.L. Suarez-Pinzon, D. Kao, R.V. Rajotte, and J.F. Elliott. 1997. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent β cell destruction in diabetic NOD mice. Transplantation. 64:1040-1049.
46. Marth, T., W. Strober, and B.L. Kelsall. 1996. High dose oral tolerance in ovalbumin TCR-transgenic mice. J. Immunol. 157:2348-2357.
47. Marth, T., W. Strober, R.A. Seder, and B.L. Kelsall. 1997. Regulation of transforming growth factor-β production by interleukin-12. Eur. J. Immunol. 27:1213-1220.
48. + suppressor T cell, NY4.2 in the prevention of autoimmune IDDM in NOD mice. J. Autoimmun. 10:299-307.
49. Kato, K., O. Shimozato, K. Hoshi, H. Wakimoto, H. Hamada, H. Yagita, and K. Okumura. 1996. Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc. Natl. Acad. Sci. USA. 93:9085-9089.